LinkOPH

Aggregated links in Ophthalmology

Main menu

Skip to content
  • Home
  • Blogs
  • Podcasts
  • Video
  • Clinical Trials
  • Peer-reviewed
  • Twitter
  • About

Sub menu

  • Refractive
    • Optic
  • Cornea
    • Conjunctiva
  • Glaucoma
  • Cataract
  • Retina
  • Uveitis
  • Infectious
  • Pediatrics
  • Neuro
  • Business
Uncategorized

GenSight Biologics Announces Regulatory Authorization for Early Access Treatment with GS010/LUMEVOQ® in Israel

by Business Wire • 2025/12/22

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…

Read more →

Uncategorized

Healio announces appointment of first chief AI officer

by Healio ophthalmology • 2025/12/22

Joan-Marie Stiglich, ELS, who has been with The Wyanoke Group for 31 years, will oversee Healio AI in the newly-created role, chief AI officer.Healio’s flagship AI product, Healio AI is a generative tool that is updated daily to deliver evidence-based …

Read more →

Uncategorized

Oral micronutrients show no impact on GA lesion growth

by Healio ophthalmology • 2025/12/22

ORLANDO — Oral micronutrient supplementation showed no benefit on geographic atrophy lesion growth among a patient group from the OAKS and DERBY trials, according to a speaker.“We have had many post hoc analyses of recent trials that have shown that, p…

Read more →

Uncategorized

Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease

by Business Wire • 2025/12/22

WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced that the U.S…

Read more →

News

The 12 Dangers of Christmas

by Medscape • 2025/12/22

Echoing the 12 Days of Christmas, this festive guide outlines the seasonal risks clinicians can help patients avoid. Medscape News UK

Read more →

News

Aflibercept 8 mg Promising Alternative to 2 mg for PCV

by Medscape • 2025/12/22

Aflibercept 8 mg provides similar outcomes for vision and eye structure as the 2-mg dose in patients with polypoidal choroidal vasculopathy, a recent study finds. Medscape Medical News

Read more →

Page 99 of 7939
« 1 … 97 98 99 100 101 … 7,939 »

Tags

Anesthesiology Article Cardiac Surgery Cardiology Clinical Summary Commentary Critical Care Dermatology Diabetes & Endocrinology Diagnostics Emergency Medicine ENT Exclusive Eye Health / Blindness Family Medicine/Primary Care Genetics GI Informatics Internal Medicine Journal Article Materials Medicine Nanomedicine Neurology Neurosurgery News News Alert Ob/Gyn Oncology Ophthalmology Orthopedic Surgery Pathology Pediatrics Plastic Surgery Psychiatry Public Health Radiology Rehab Sports Medicine surgery Telemedicine Thoracic Surgery Urology Vascular Surgery Viewpoint

Archives

Sources

  • Advanced Ocular Care – Issues
  • Advanced Ocular Care – News
  • Business Wire
  • Business Wire Health: Optical News
  • Cataract & Refractive Surgery Today – Issues
  • Cataract & Refractive Surgery Today – News
  • Clinical Trials Updates
  • EyeDocNews Blog
  • Eyewire Today
  • Healio
  • IOVS/SciVee
  • Irv Arons' Journal
  • Medgadget
  • Medical News Today
  • MedicineWorld
  • MedPage Today
  • Medscape
  • Medscape Ophthalmology Podcast
  • MedscapeCME Ophthalmology Podcast
  • ModernMedicine – Ophthalmology
  • NeLM – Ophthalmology
  • NHS Evidence
  • Ophthalmology Update
  • OphthalmologyWeb
  • OphthalmologyWeb Videos
  • OphthoBook (videos)
  • RetinaEyeDoctor.com
  • Root Atlas
  • ScienceDaily
  • The Medical News

Copyright © 2026 LinkOPH. All Rights Reserved. The Magazine Basic Theme by bavotasan.com.